Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Improving the Care Process for Patients with Advanced Prostate Cancer
    Release Date:
    Partner: The American Urological Association Education and Research, Inc.; Astellas
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Optimizing Care for patients with locally advanced or metastatic Urothelial Carcinoma (la/mUC)
    Release Date:
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Canada
    PARP-Inhibitor Combination Therapies: Personalized Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Canada
    Developing Educational Initiatives for ALK+ Metastatic Non-small Cell Lung Cancer Tyrosine Kinase Inhibitors Therapy
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Canada
    Accelerating biomarker testing for optimized metastatic colorectal cancer treatment planning across Canada
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Integrin beta-6 (IB6) Sigvotatug Vedotin (SV) Translational and Pre-Clinical Research
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    2025 Inflammatory Bowel Disease (IBD) Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    PARP-inhibitor Combination Treatments: Efficacy and Safety in a New Era of metastatic Castration Resistant Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology China
    Transthyretin Cardiac Amyloidosis Fellowship - United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Advances in Migraine Management
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pneumococcal Disease Prevention
    Release Date:
    Chronic Pain
    Release Date:
    Bacterial Infections
    Release Date:
    Pharmacy Pneumococcal Disease Prevention
    Release Date:
    Smoking Cessation
    Release Date:
    Non-Small Cell Lung Cancer
    Release Date:
    Cardiovascular Risk in Rheumatoid Arthritis
    Release Date:
    Opioid Pain
    Release Date:
    Adult Pneumococcal Disease Prevention
    Release Date:
    Prevention of Stroke in Women
    Release Date:
    Oncology Educational Needs Assessments
    Release Date:
    Extension Grant
    Release Date: